Judge Questions Drugmaker’s Right to Sue the FDA for Inaction on Generic Lipitor

Drug Industry Daily
A A
A federal judge harshly questioned Mylan’s standing to sue the FDA in efforts to wedge itself into the 180-day exclusivity period for a generic version of the blockbuster drug Lipitor.

To View This Article:

Login

Subscribe To Drug Industry Daily